Skip to content

The European Union Falsified Medicines Directive (FMD) is designed to protect public health by securing the pharmaceutical supply chain against counterfeit medicines. It’s a rigorous set of rules that pharmaceutical companies operating in Europe need to abide by, and at Sharp we can help.

Our comprehensive serialisation service can help you meet the criteria demanded by the FMD by making your products fully traceable and trackable through their supply chain.

We’re able to aggregate serial numbers for up to five levels of packaging in multiple formats, from the cavities of our blister packs through to the pallets they ship in, so you’ll always be able to identify where your products are – and where they came from.

Great to meet new and familiar faces at #CTSBoston2019 this week!
If you missed our round table discussion on how to leverage #ClinicalIRT to improve #clinicaltrial efficiency, you can watch our on-demand webinar here: https://t.co/oHjmki0sPi
@proventaintl

#CTSBoston2019 has officially come to an end! Thank you to all our sponsors and partners for supporting us in this educational day of executive networking and building strategic partnerships! Hope to see you all again in our next CTS Strategy Meeting. https://t.co/KbkDfwYIRB

#Webinar | Are you paying too much tax on your #clinicalsupply shipments? Join Sharp for a live webinar in discussing how you can optimise your #clinicaltrial supply shipments into & out of the UK, from both non-EU and EU locations.
Click to register: https://t.co/o2P1Qlwx9E